Acadia Pharmaceuticals Stock Price - ACAD

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 47.60 ▲ 0.07 (0.15%)
Company Name Stock Ticker Symbol Market Type
Acadia Pharmaceuticals Inc ACAD NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  1.34 2.9% 47.53 47.9343 45.28 45.46 46.19 19:39:55
Bid Price Ask Price Spread Spread % News
47.00 47.88 0.88 1.84% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
12,391 1,274,469 $ 47.11 $ 60,045,474 1,394,121 14.01 - 51.00
Last Trade Time Type Quantity Stock Price Currency
19:39:55 formt 100 $ 47.60 USD

Acadia Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 7.32B 154.03M $ -245.19M -1.95 -39.66 153.46M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 13.00 0.40%

more financials information »

Acadia Pharmaceuticals News

Loading Messages....

Latest ACAD Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACAD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week46.4447.934344.1645.941,394,3271.092.35%
1 Month41.7147.934339.7543.971,274,3155.8213.95%
3 Months28.1051.0023.7739.992,137,46819.4369.15%
6 Months24.5651.0021.5634.571,618,25722.9793.53%
1 Year18.4451.0014.0128.521,605,29829.09157.75%
3 Years29.6051.0012.7725.841,980,94917.9360.57%
5 Years28.7751.9912.7728.241,932,66118.7665.21%

Acadia Pharmaceuticals Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Your Recent History
Acadia Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.